Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board

A California biotech launched on Tuesday morning to try to bring a niche pain drug, approved in Italy for more than a decade, to the US.

Investors are pumping $125 million into the company, called …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registeration number 16808844